0000000000198962
AUTHOR
Johannes Schwarz
Practical importance of neuroprotection in Parkinson's disease.
Consensus could be reached that there is overwhelming evidence of preclinical neuroprotection. However, the evidence of neuroprotection/neurorescue under clinical conditions is limited. Lessons from clinical trials designed to show neuroprotection (selegiline, amantadine, dopamine agonists) demonstrate that with the drugs available neuroprotection/neurorescue has to start as early as possible. A PET-controlled clinical trial with ropinirole shows that there seems to be a good chance for neuroprotection in the early phase of Parkinson's disease in patients treated from the very beginning of the disease while there is no such benefit in patients with a late start of a neuroprotective therapeu…
Population trends of birds across the iron curtain: Brain matters
One approach to assess human impact on species’ population dynamics is to correlate ecological traits of species with their long-term population trends. Yet, few studies investigated population trends in multiple regions that differ in human impact to reveal which traits explain population trends over larger geographic areas and which only regionally. We examined the relationship between various species traits and long-term population trends of 57 common passerine bird species from 1991 to 2007 in three adjacent regions in central Europe that experienced differences in socioeconomic history: North-Western Germany, Eastern Germany and the Czech Republic. We tested effects of habitat, dietary…